Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Archives of Allergy and Immunology|August 3, 2004
Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patientsR E Rossi, G MonasteroloInternational Journal of Immunopathology and Pharmacology|May 13, 2005
A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthmaR E Rossi, G MonasteroloEuropean Annals of Allergy and Clinical Immunology|July 23, 2010
The biological potency of different extracts for sublingual immunotherapy assessed by skin prick testsR Rossi, G Monasterolo, G PassalacquaClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 24, 1998
A comparative study of the tryptase release test and the cellular allergen stimulation test (CAST) in mite sensitive patientsR E Rossi, G Monasterolo, D OpertiAllergy|December 12, 2001
Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollenR E Rossi, G Monasterolo, S MonasteroloAllergy|August 13, 2003
Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profilesR E Rossi, G Monasterolo, S MonasteroloForensic Science International|June 5, 1999
Fatal anaphylactic shock during a fluorescein angiographyV Fineschi, G Monasterolo, R Rosi, et al.Allergy|December 1, 1996
Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen-related allergy to birch and appleR E Rossi, G Monasterolo, D Operti, et al.International Archives of Allergy and Immunology|September 22, 2005
Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosisR E Rossi, G Monasterolo, G Coco, et al.Allergy|March 22, 2000
Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with specific IgE to Phleum pratenseR E Rossi, G Monasterolo, D Operti, et al.Pageof 2